New Delhi: The Subject Expert Committee on Corona Virus of the Central Drugs Standard Control Organisation (CDSCO) on Thursday recommended mixing Covishield and Covaxin and studying it. The expert panel has also recommended the mixing of Bharat Biotech Covaxin and Nasal Vaccine.
It has also recommended that the Biological E children's vaccine be approved for the clinical trial. However, the final decision will be taken by the Drugs Controller General of India (DCGI). The Christian Medical College (CMC) in Vellore, Tamil Nadu, had applied for a study on the mixing dose of Covishield and Covaxin. On this, the Expert Committee has recommended that CMC should be allowed to conduct the study.
According to media reports, the Expert Committee has recommended the CMC to approve the clinical trial of Phase-IV, which will provide Covishield and Covaxin supplements to 300 people. The purpose of the study is to find out if someone can be given different vaccine supplements to complete the vaccination course. Hyderabad-based India is also working on the nasal vaccine of the biotech corona. The Expert Committee has also recommended Bharat biotech to study the mixing of the Covaxin and Nasal vaccine.